The human health impact of AFB1 exposure is widespread in developing countries, is known to cause teratogenicity, immunotoxicity, hepatotoxicity and even death in farm animals and humans. As information has accumulated on toxicological effects of AFB1, preventive strategies whose objective is to reduce the risks to human health have been implemented. Chemical, physical and biological strategies for the control and prevention of aflatoxicosis and AFB1-associated diseases are described. In a primary prevention trial, the purpose is to reduce exposure to AFB1 in the diet. In secondary prevention trials, one goal is to modulate the metabolism of ingested AFB1 to enhance detoxification processes, thereby reducing internal doses and subsequent risk. This information suggested the probable application of different strategies as an alternative method to avoid the effects produced by the AFB1. The extent to which these interventions may ultimately modify the hazard in high-risk populations is an area that needs further investigation.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Blount, W. P. Turkey, “X” disease. J. Br. Turkey Fed. 9, 55–58 (1961).
Kensler, T. W., Roebuck, B. D., Wogan, G. N. & Groopman, J. D. Aflatoxin: A 50-year odyssey of mechanistic and translational toxicology. Tox. Sci. 120, S28–S48 (2011).
Hendricks, J. D. Carcinogenicity of aflatoxins in nonmammalian organisms. in The Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance (eds Eaton, D. L. & Groopman, J. D.) 103–136 (Academic Press, New York, 1994).
Turkez, H. & Geyikoglu, F. Boric acid: a potent chemoprotective agent against aflatoxin B1 toxicity in human blood. Cytotechnology 62, 157–165 (2010).
Groopman, J. D., Kensler, T. W. & Wild, C. P. Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu. Rev. Public. Health 29, 187–203 (2008).
Phillips, T. D. Dietary clay in the chemoprevention of aflatoxin-induced disease. Tox. Sci. 52, 118–126 (1999).
Bennett, J. W. & Klich, M. Mycotoxins. Clin. Microbiol. Rev. 16, 497–516 (2003).
Brahmi, D. et al. Chemopreventive effect of cactus Opuntia ficus indica on oxidative stress and genotoxicity of aflatoxin B1. Nutrition & Metabolism 8, 1–16 (2011).
Sudakin, D. L. Dietary aflatoxin exposure and chemoprevention of cancer: a critical review. Clin. Tox. 41, 195–204 (2003).
Park, D. L. Effect of processing on aflatoxin. Adv. Exp. Med. Biol. 504, 173–179 (2002).
Simonich, M. T. et al. Natural chlorophyll inhibits aflatoxin B1 induced multi-organ carcinogenesis in the rat. Carcinogenesis 28, 1294–1302 (2007).
Egner, P. et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Nat. Acad. Sci. 98, 14601–14606 (2001).
Jubert, C. et al. Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B1 pharmacokinetics in human volunteers. Cancer Prev. Res. 2, 1015–1022 (2009).
Fahey, J. W. et al. Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers of mammalian phase 2 cytoprotective genes. Carcinogenesis 26, 1247–1255 (2005).
Hayes J. D. et al. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel Alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide. Biochem. J. 279, 385–398 (1991).
Guyonned, D., Belloir, C., Suscheted, M., Siess, M. H. & Le Bon, A.-M. Mechanisms of protection against aflatoxin B1 genotoxicity in rats treated by organ sulfur compounds from garlic. Carcinogenesis 23, 1335–1341 (2002).
Moyers, S. B. & Kumar, N. B. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nut. Rev. 62, 204–211 (2004).
Wu, H. C. et al. Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis 28, 995–999 (2007).
Yang, C. S. et al. Molecular targets for the cancer preventive activity of tea polyphenols. Mol. Carcinog. 45, 431–435 (2006).
Luo, H. et al. Phase II a chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 27, 262–268 (2006).
Tang, L. et al. Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis 29, 411–417 (2008).
McLellan, L. I., Judah, D. J., Neal, G. E. & Hayes, J. D. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors. Biochem. J. 300, 117–124 (1994).
Roebuck, B. D., Liu Y. L., Rogers, A. E., Groopman J. D. & Kensler T. W. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyll-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Cancer Res. 51, 5501–5506 (1991).
Bolton M. G. et al. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. Cancer Res. 53, 3499–3504 (1993).
Langouet, S. et al. Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane. Chem. Res. Toxicol. 13, 245–252 (2000).
Talalay, P., Dinkova-Kostova, A. T. & Holtzclaw, W. D. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv. Enzyme Regul. 43, 121–134 (2003).
Fahey, J. W. & Kensler, T. W. Role of dietary supplements/nutraceuticals in chemoprevention through induction of cytoprotective enzymes. Chem. Res. Toxicol. 20, 572–576 (2007).
Gross-Steinmeyer, K. et al. Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Tox. Sci. 116, 422–432 (2010).
Fahey, J. W. et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl. Acad. Sci. U.S.A. 99, 7610–7615 (2002).
Dinkova-Kostova, A. T. et al. Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol. Biomarkers Prev. 16, 847–851 (2007).
Kensler, T. W. et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo Township, Qidong, People’s Republic of china. Cancer Epidemiol. Biomarkers Prev. 14, 2605–2613 (2005).
Heber, D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J. Postgrad. Med. 50, 145–149 (2004).
Ramadan, M. F. & Morsel, J. T. Oil cactus pear (Opuntia ficus-indica). Food Chem. 82, 339–345 (2003).
Stintzing, F. C. & Carle, R. Cactus stems (Opuntia spp.): a review on their chemistry, technology, and uses. Mol. Nutr. Food Res. 49, 175–194 (2005).
Tesoriere, L., Fazzari, M., Allegra, M. & Livrea, M. A. Biothiols, taurine, and lipid soluble antioxidants in the edible pulp of Sicilian cactus pear (Opuntia ficusindica) fruits and changes of bioactive juice components upon industrial processing. J. Agric. Food Chem. 20, 7851–7855 (2005).
Shon, M. Y., Choi, S. D., Kahng, G. G., Nam, S. H. & Sung, N. J. Antimutagenic, antioxidant and free radical scavenging activity of ethyl acetate extracts from white, yellow and red onions. Food Chem. Toxicol. 42, 659–666 (2004).
Abdel-Wahahab, M. A. et al. Zizyphus spina christi extract protects against aflatoxin B1-initiated hepatic carcinogenicity. Afr. J. Trad. CAM 4, 248–256 (2007).
Cavin, C., Holzhäuser, D., Constable, A., Huggett, A. C. & Schilter, B. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. Carcinogenesis 19, 1369–1375 (1998).
Pérez, A. & Hurtado, T. Actividad antimutagénica de extractos vegetales sobre la aflatoxina B1. Rev. Cubana Aliment. Nutr. 11, 10–14 (1997).
Verma, R. J. & Nair, A. Vitamin E ameliorate aflatoxin-induced biochemical changes in the testis of mice. Asian J. Androl. 3, 305–309 (2008).
Madrigal-Santillán, E. et al. Antigenotoxic studies of different substances to reduce the DNA damage in-duced by aflatoxin B1 and ochratoxin A. Toxins 2, 738–757 (2010).
DeFlora, S. & Ferguson, I. R. Overview of mechanisms of cancer chemopreventive agents. Mutat. Res. 591, 8–15 (2005).
Yang, C.-F. et al. Inhibition of ebselen on aflatoxin B1-induced hepatocarcinogenesis in Fisher 344 rats. Carcinogenesis 21, 2237–2243 (2000).
Mogilnaya, O. A., Puzyr, A. P., Baron, A. V. & Bondar, V. S. Hematological parameters and the state of liver cells of rats after oral administration of aflatoxin B1 alone and together with nanodiamonds. Nanoescale Res. Lett. 5, 908–912 (2010).
Phillips, T. D. et al. Reducing human exposure to aflatoxin through the use of clay: a review. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess 25, 134–145 (2008)
Kannewischer, I., Tenorio, M. G., White, G. N. & Dixon, J. B. Smectite Clays as Adsorbents of Aflatoxin B1: Initial Steps. Clay Science, Japan. 12Suppl 2, 99–204 (2006).
Mulder, I., Barrientos, A. L., Tenorio, M. G., White, G. N. & Dixon J. B. Smectite clay sequestration of aflatoxin B1: particle size and morphology. Clays and Clay Minerals 56, 558–570 (2008).
Tenorio, M. G., Mulder, I., Barrientos, A. L. & Dixon, J. B. Smectite clay adsorption of aflatoxin vs. octahedral composition and alteration history indicated by FTIR. Clays and Clay Minerals 56, 571–578 (2008).
Strosnider, H. et al. Workgroup report: public health strategies for reducing aflatoxin exposure in developing countries. Environ. Health Perspect. 114, 1898–1903 (2006).
Liu, Y. & Wu, F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ. Health Perspect. 118, 818–824 (2010).
Turner, P. C. et al. Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int. J. Epidemiol. 36, 1119–1125 (2007).
About this article
Cite this article
Valencia-Quintana, R., Sánchez-Alarcón, J., Tenorio, M.G. et al. Preventive strategies aimed at reducing the health risks of Aflatoxin B1 . Toxicol. Environ. Health Sci. 4, 71–79 (2012). https://doi.org/10.1007/s13530-012-0119-4
- Aflatoxin B1
- HCC risks
- Aspergillus flavus
- DNA damage